Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • 1011-17: Optimizing the Aging Journey: Psychopharmacologic Approaches to Geriatric Anxiety, Depression, Delirium and Dementia

    Contains 5 Component(s), Includes Credits

    Presenter: Grace Nadolny, MD 1.5 pharmacology contact hours

    1011-17: Optimizing the Aging Journey: Psychopharmacologic Approaches to Geriatric Anxiety, Depression, Delirium and Dementia

    This session will discuss psychiatric disorders in elderly populations and best choices for treatment.

    Presenter: Grace Nadolny, MD

    Disclosures: Discussion of off-label uses (using products for a purpose other than that for which it was approved by the Food and Drug Administration, or FDA) occur in this presentation.


    Session Length: 
    1 hour 27 minutes

    Target Audience: RN, APRN 

    Session Objectives:
    Upon completion of this presentation, the participant will be able to:

    1. Relate the prevalence, physiology, manifestation, and diagnosis of depressive disorder to the elderly population.
    2. Discuss research related to treatment of psychiatric disorders in an elderly population.
    3. Examine practical treatment applications for “late life mood disorders”.
    4. Explore etiology and symptoms of dementias, their differences, and best choices for treatment of cognitive disorders in the elderly.

    Keywords: Geriatrics, Dementia, Delirium, Pharmacology


    Continuing Nursing Education

    1.5 pharmacology contact hours.* In order to receive contact hours, you must: Listen to presentation, complete an evaluation and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Originally Presented
    APNA 15th Annual Clinical Psychopharmacology Institute
    Hyatt Regency Baltimore on the Inner Harbor
    Saturday, June 10, 2017
    3:30pm – 5:00pm

    The contact hours for this session expire: July 1, 2020

  • 1008-17: The Management of Mood and Anxiety Disorders in Pregnancy and Postpartum

    Contains 5 Component(s), Includes Credits

    Presenter: Lauren M. Osborne, MD 1.5 pharmacology contact hours

    1008-17: The Management of Mood and Anxiety Disorders in Pregnancy and Postpartum

    The purpose of this session is to provide evidence-based discussion of the management of mood and anxiety disorders in pregnancy and postpartum.

    Presenter: Lauren M. Osborne, MD

    Disclosures: Discussion of off-label uses (using products for a purpose other than that for which it was approved by the Food and Drug Administration, or FDA) will occur in this presentation.


    Session Length: 1 hour 26 minutes

    Target Audience: RN, APRN 


    Session Objectives:

    Upon completion of this presentation, the participant will be able to:

    1. Define the potential risks and benefits of psychiatric medication in pregnancy.
    2. Define the potential risks of no treatment for psychiatric illness during and after pregnancy.
    3. Identify 2 or more treatment alternatives to psychiatric medication during and after pregnancy.

    Keywords: Practice, Mood Disorders, Pregnancy, Pharmacology


    Continuing Nursing Education

    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, earn a passing score on the post test and complete an evaluation before the expiration date. You will have 5 tries to correctly answer the questions on the post test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented

    APNA 15th Annual Clinical Psychopharmacology Institute
    Hyatt Regency Baltimore on the Inner Harbor
    Saturday, June 10, 2017
    9:45am – 11:15am

    The contact hours for this session expire: July 1, 2020

  • 1010-17: Employing Multiple Mechanisms with Downstream Effects: Contemporary Psychopharmacologic Approaches

    Contains 5 Component(s), Includes Credits

    Presenter: Christian J. Teter, PharmD, BCPP 1.25 pharmacology contact hours

    1010-17: Employing Multiple Mechanisms with Downstream Effects: Contemporary Psychopharmacologic Approaches

    This session will enable the learner to improve their knowledge and skills related to the use of psychopharmacologic medications.

    Presenter: Christian J. Teter, PharmD, BCPP

    Disclosures: The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label uses will not be discussed during this presentation.


    Session Length:
    1 hour 13 minutes

    Target Audience: RN, APRN 


    Session Objectives:

    Upon completion of this presentation, the participant will be able to:

    1. Explain the initial and downstream mechanisms of action of psychopharmacologic medications.
    2. Distinguish between pre- and post-synaptic CNS effects of psychopharmacologic medications.
    3. Demonstrate the medication management of patients with various psychiatric and substance use disorder symptoms based upon initial and downstream effects of psychopharmacologic medications.

    Keywords: Pharmacology, Practice, APRN Practice


    Continuing Nursing Education

    1.25 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, earn a passing score on the post test and complete an evaluation before the expiration date. You will have 5 tries to correctly answer the questions on the post test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented

    APNA 15th Annual Clinical Psychopharmacology Institute
    Hyatt Regency Baltimore on the Inner Harbor
    Saturday, June 10, 2017
    1:45pm – 3:15pm

    The contact hours for this session expire: July 1, 2020

  • 1003-17: Clinical Treatment Targets in Addictions

    Contains 5 Component(s), Includes Credits

    Presenter: Lorenzo Leggio, MD, PhD, MSc 1.5 pharmacology contact hours

    1003-17: Clinical Treatment Targets in Addictions

    This session will review approved medications and other medications or pharmacological targets under investigation for the treatment of alcohol use disorder. 

    Presenter: Lorenzo Leggio, MD, PhD, MSc

    Disclosures: Dr. Leggio is a federal employee at the National Institutes of Health (NIH). In addition to the intramural NIH funding, he is the PI of a clinical study to be conducted in his NIH laboratory; this study has received partial funding from the Peter G. Dodge Foundation (PGDF). Dr. Leggio serves as an Editor-in-Chief for 'Alcohol and Alcoholism' (Oxford Press and MCA). Discussion of off-label uses (using products for a purpose other than that for which it was approved by the Food and Drug Administration, or FDA) will occur in this presentation.


    Session Length:
    1 hour 25 minutes

    Target Audience: RN, APRN 


    Session Objectives:

    Upon completion of this presentation, the participant will be able to:

    1. Identify FDA Approved medications.
    2. Identify non-FDA approved medications with off label use.
    3. Identify novel potential pharmacological targets under investigation.

    Keywords: Addictions, Practice, Pharmacology

    Continuing Nursing Education
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented

    APNA 15th Annual Clinical Psychopharmacology Institute
    Hyatt Regency Baltimore on the Inner Harbor
    Friday, June 9, 2017
    9:45am - 11:15am

    The contact hours for this session expire: July 1, 2020

  • 1001-17: The Power of Zzzzs: Sleep Solutions for Psychiatric Nursing Practice

    Contains 5 Component(s), Includes Credits

    Presenter: Joseph M. Holshoe, MSN, PMHNP-BC 2.0 pharmacology contact hours

    1001-17: The Power of Zzzzs: Sleep Solutions for Psychiatric Nursing Practice

    This lecture will provide a comprehensive overview of sleep and the role of role of psychiatric nurses in the management of sleep. It will review the biology of sleep, common sleep disorders, review non-pharmacological and pharmacological treatments for sleep, and explore the role of psychiatric nurses in assessing and managing sleep to improve psychiatric outcomes.

    Presenter: Joseph M. Holshoe, MSN, PMHNP-BC

    Disclosures: Discussion of off-label uses (using products for a purpose other than that for which it was approved by the Food and Drug Administration, or FDA) occur in this presentation.


    Session Length
    1 hour 58 minutes

    Target AudienceRN, APRN     


    Session Objectives:

    Upon completion of this presentation, the participant will be able to:

    1. Discuss the health effects of sleep and the impact of disordered sleep on mental health.
    2. Explore the mechanisms of human sleep and sleep architecture.
    3. Review common sleep diagnoses and treatments.
    4. Explore sleep psychopharmacology and how psychiatric meds effect sleep.
    5. Review practical solutions for assessing and managing sleep in patients with psychiatric illness.

    Keywords: Sleep Architecture, Sleep Disorders, Circadian Rhythm, Pharmacology


    Continuing Nursing Education

    2.0 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented

    APNA 15th Annual Clinical Psychopharmacology Institute 
    Hyatt Regency Baltimore on the Inner Harbor 
    Thursday, June 8, 2017 
    5:00pm – 7:00pm

    The contact hours for this session expire: July 1, 2020

  • APNA Transitions in Practice Certificate Program

    Contains 31 Component(s), Includes Credits

    The APNA Transitions in Practice (ATP) Certificate Program has been developed to provide and improve the foundational knowledge of RNs and is presented by recognized expert leaders in the PMH nursing field. The program focuses on best practices and evidence-based nursing knowledge that will optimize success in nursing practice and improve healthcare outcomes for persons with mental health disorders.

    APNA Transitions in Practice Certificate Program

    image

    The APNA Transitions in Practice (ATP) Certificate Program has been developed to provide and improve the foundational knowledge of RNs and is presented by recognized expert leaders in the Psychiatric-Mental Health (PMH) nursing field. The program focuses on best practices and evidence-based nursing knowledge that will optimize success in nursing practice and improve healthcare outcomes for persons with mental health disorders.

    The content is self-paced with supplemental activities (content handouts, glossary of terms, references, and case examples) as learners progress through the program.

    Registrants have 90 days from date of registration to complete the content and earn continuing education contact hours.

    Target Audience: RN

    Disclosures: The presenters and the activity planners have no conflicts of interest to disclose.

    Program Outcomes

    1. Introduce evidence based strategies for providing safe and effective nursing care for people with psychiatric-mental health disorders.
    2. Provide education that promotes the acquisition of foundational evidence-based knowledge related to psychiatric-mental health nursing through case study analysis and post-test questions.
    3. Provide evidence-based tools and strategies to facilitate nurses developing a person centered plan of care for people with mental health disorders.

    Pricing 
    APNA Member: $200.00 
    Non Member: $250.00 

    For organizations interested in purchasing the program in bulk, please email atp@apna.org


    Program Format

    Program Foreword
    • The Importance of Therapeutic Engagement

    Module 1: Psychiatric-Mental Health Disorders and Psychopharmacology
    • Depressive and Anxiety Disorders
    • Psychotic Disorders
    • Psychopharmacology 101

    Module 2: Risk Assessments, Addictions and Co-morbid Disorders
    • Mental Status Exam and Risk Assessment
    • Substance-Related Disorders
    • Medical Comorbid Illness in Psychiatric Patients

    Module 3: Recovery
    • Using the Recovery Model in Nursing Practice
    • Cultural Awareness
    • Trauma and Recovery
    • Post Traumatic Stress Disorder and Trauma Informed Care

    Module 4: Therapeutic Environment
    • Risky Business: Walking the Boundaries Tightrope
    • Therapeutic Engagement in De-Escalation?
    • Key Elements of a Safe Environment


    Nursing Continuing Professional Development
    The American Psychiatric Nurses Association Transitions in Practice (ATP) Certificate program is a 4-module nursing education program that includes faculty presentations, case studies, post-tests and evaluations of the content. The ATP program is worth 15.0 nursing continuing professional development contact hours. In order to receive contact hours for the program, participants must: Complete the overall pre-test, view the program in its entirety (foreword, modules 1-4), complete the end-of-module evaluations, and earn a passing score of at least 80% on the post-test for each module during the allotted access period. Participants will have 5 tries to correctly answer the questions on the post-test. Once the overall post-test and evaluation have been completed, the certificate will be generated online, available for print immediately. Credit cannot be earned unless all steps are completed. 

    The American Psychiatric Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

    Release Date: July 1, 2015, Revised, June 1, 2017
    The contact hours for this program expire: June 30, 2020


    Cancellation Policy

    We do not issue refunds for eLearning purchases once the order is accomplished and the corresponding course information is accessed. However, we understand that exceptional circumstances can take place with regard to the character of the product we supply. Therefore, we do honor requests for a refund in situations outlined here

    APNA offers ATP participants the ability to retake the program at a specially discounted rate if it is not completed within the prescribed timeframe of 90 days. The cost of the retake program is $125.00. To qualify for this discount, application and payment must be made to APNA within six months of expiration of the initial registration. The retake may require the applicant to restart the program and previous work may not count toward completion. Only one retake will be allowed. To request this discounted pricing option for your retake, please email atp@apna.org



    Citation

    To reference material from the APNA Transitions in Practice Certificate Program, please use the following citation, filling in the appropriate information indicated:

    American Psychiatric Nurses Association (2015). APNA Transitions in Practice Certificate Program [Module Number: Presentation Title]. Retrieved from https://e-learning.apna.org/products/apna-transitions-in-practice-certificate-program




    Diane Allen, MN, RN-BC, NEA-BC
    Joanne Bartlett, PMHNP-BC
    Julie Carbray, PhD, FPMHNP, PMHCNS, APN
    Dawn Cogliser, MSN, RN-BC
    Nancy Dillon, PhD, RN, CNS
    Diane Esposito, PhD, ARNP, PMHCNS-BC
    Carole Farley-Toombs, MS, RN, NEA, BC
    Kathy Lehmann, EdD(c), RN-BC PMHN
    Barbara Limandri, PhD, PMHNP, BC
    Jeannine Loucks, MSN, RN-BC PMH
    Pamela E. Marcus, RN, APRN, PMH-BC
    Kris A. McLoughlin, DNP, APRN, PMHCNS-BC, FAAN
    Cheryl Puntil, CNS, MN, APRN, PMHCNS, BC
    Joyce Shea, DNSc, APRN, BC
    Linda Stanley, MSN
    Gail Stern, MSN, PMHCNS-BC
    Matthew Tierney, APRN, MS

  • 2019 Effective Treatments for Opioid Use Disorder: Educating & Empowering All Registered Nurses (RN) During an Epidemic

    Contains 7 Component(s), Includes Credits

    This continuing educational activity was developed by the American Psychiatric Nurses Association to provide education to all nurses regarding epidemic opioid use in the U.S. and to answer the question, “What can nurses do?” to address this growing problem. Almost 4 million nurses can make a difference!

    2019 Effective Treatments for Opioid Use Disorder:
    Educating & Empowering All Registered Nurses (RN) During an Epidemic

    This continuing educational activity was developed by the American Psychiatric Nurses Association to provide education to all nurses regarding the epidemic of opioid use in the U.S. and to answer the question, 
    "What can nurses do?" to address this growing problem.

    Almost 4 million nurses can make a difference!


    In this course you will learn about the epidemiology surrounding the use of heroin and opioid use in the United States. The Scope and Standards for the psychiatric-mental health nurse will be the foundation for assessing the patient at risk for opioid use disorders. Some of the risk factors associated with opioid use disorder will be presented. Various treatment options will be discussed, along with strategies nurses can employ to help patients to select the appropriate individualized treatment plan combining psychosocial and medication assisted interventions that meet their goals.


    Presenter:  Laura G. Leahy, DrNP, APRN, PMH-CNS/FNP, CARN-AP, FAANP
    Contributing Faculty:  Carolyn Baird, DNP, MBA, RN-BC, CARN-AP, CCDPD, FIAAN; Susan Caverly, PhD, APRN, RN-BC, PLLC; Mary Kastner, PMHCNS, PMHNP-BC; Matthew Tierney, MSN, PMHNP-BC, FANP-BC, FAAN

    Disclosures: The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will be discussed during this presentation.


    Session Length:
     1 hour 30 minutes

    Target Audience: RN


    Session Outcomes:  
    Upon completion of this presentation, the participant will be able to:

    1. Identify key morbidity and mortality statistics related to heroin and prescription opioid use in recent years.
    2. Identify psychotherapeutic treatment options for patients with opioid use disorders.
    3. Describe at least one way to increase access to treatment for opioid use disorders in the settings or communities where you work as a psychiatric nurse.

    Keywords: Opioid Use Disorder, Opioids, Heroin

    Price: Free


    Continuing Nursing Education: 
    1.5 contact hours. * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test. Once you have passed the post-test and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed. 

    The American Psychiatric Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. 

    Release Date: August 28, 2019
    The contact hours for this session expire: September 30, 2022